Chronic Myelogenous Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Radiation
- +3 more
- New Hyde Park, New YorkCohen Children's Medical Center
2022-04-06
Apr 6, 2022N
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
- Atlanta, GeorgiaNorthside Hospital
2022-04-04
Apr 4, 2022N
Completed
- Acute Myelogenous Leukemia
- +6 more
- This is a non-interventional study
- Bakersfield, California
- +19 more
2022-04-04
Apr 4, 2022N
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022N
Active, not recruiting
- Chronic Myelogenous Leukemia
- Chicago, Illinois
- +87 more
2022-03-21
Mar 21, 2022C
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
- Scottsdale, Arizona
- +31 more
2022-03-08
Mar 8, 2022W
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
- Atlanta, Georgia
- +2 more
2022-02-09
Feb 9, 2022C
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
- Duarte, California
- +16 more
2022-02-25
Feb 25, 2022H
Active, not recruiting
- Myeloid Malignancies
- +4 more
- Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
- Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
- Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
2022-02-25
Feb 25, 2022B
Not yet recruiting
- Hematologic Diseases
- +5 more
- CliniMACS
- +7 more
- Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
2022-02-21
Feb 21, 2022N
Recruiting
- Chronic Myelogenous Leukemia
- ABL001 40mg BID
- +2 more
- Linz, Austria
- +24 more
2022-02-17
Feb 17, 2022A
Recruiting
- Chronic Myelogenous Leukemia
- Beirut, LebanonAmerican University of Beirut Medical Center
2022-02-14
Feb 14, 2022M
Recruiting
- Chronic Myelogenous Leukemia
- Chart Review
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2022-02-08
Feb 8, 2022N
Active, not recruiting
- CML
- +3 more
- Asciminib add-on
- +2 more
- Augusta, Georgia
- +29 more
2022-02-03
Feb 3, 2022H
Recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
2022-01-26
Jan 26, 2022H
Active, not recruiting
- Chronic Myelogenous Leukemia
- Amman, Jordan
- +4 more
2022-01-17
Jan 17, 2022N
Active, not recruiting
- Chronic Myelogenous Leukemia
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
- ABL001
- +3 more
- Boston, Massachusetts
- +18 more
2022-01-10
Jan 10, 2022V
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
- Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021N
Not yet recruiting
- Chronic Myelogenous Leukemia
- Asciminib single agent
- +6 more
- (no location specified)
2021-11-25
Nov 25, 2021W
Recruiting
- Acute Myelogenous Leukemia
- +9 more
- Winston-Salem, North CarolinaWake Forest Baptist Health
2021-11-23
Nov 23, 2021H
Completed
- Chronic Myelogenous Leukemia
- Therapy for Targeted Therapy-related Fatigue (TTF)
- Wait-List Control Condition (WLC)
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021N
Active, not recruiting
- Chronic Myelogenous Leukemia
- Nilotinib followed by treatment-free
- Fort Myers, Florida
- +113 more
2021-11-11
Nov 11, 2021M
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
- Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
2021-11-04
Nov 4, 2021S
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
- Stanford, CaliforniaStanford University
2021-10-28
Oct 28, 2021M
Completed
- Acute Myelogenous Leukemia
- +4 more
- Single Umbilical Cord Blood Unit Transplant
- +6 more
- Birmingham, Alabama
- +37 more
2021-10-13
Oct 13, 2021